The global vaginal and vulval inflammatory diseases treatment market is expected to be valued at USD 2.96 Billion in the fiscal year 2023, up from USD 2.8 Billion in 2022. With a steady CAGR of 5.8% anticipated from 2023 to 2033, the market is projected to reach approximately USD 5.21 Billion by the end of …